A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial
Not Applicable
Terminated
- Conditions
- DiabetesPregnancy
- Registration Number
- NCT02409017
- Lead Sponsor
- WellSpan Health
- Brief Summary
To assess which of two commonly utilized insulin drip protocols has better outcomes when used during the labor process.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
- a. Pregnant patients with either pre-existing diabetes or gestational diabetes type A2 who require insulin for euglycemia during labor and delivery
Exclusion Criteria
- a. Those patients who decline participation
- b. Patients less than age 18 at the time of enrollment will be excluded to protect this vulnerable patient population c. Those patients who cannot be consented d. Patients scheduled for cesarean delivery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Mean maternal glucose Labor
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of insulin resistance in gestational diabetes during labor?
How do insulin drip protocols compare to standard-of-care glucose management in diabetic pregnancies?
What biomarkers predict optimal insulin sensitivity during labor in type 1 diabetic patients?
What adverse events are associated with continuous insulin infusion during childbirth?
Are there combination therapies with insulin drips that improve maternal-fetal outcomes in diabetic labor?
Trial Locations
- Locations (1)
WellSpan York Hospital
🇺🇸York, Pennsylvania, United States
WellSpan York Hospital🇺🇸York, Pennsylvania, United States